SFCM
TNGX icon

Seven Fleet Capital Management’s Tango Therapeutics TNGX Stock Holding History

Seven Fleet Capital Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$95.7M Buy
3,228,144
+2,726,132
+543% +$67.4M 15.79% 2
2026
Q1 		$10.5M Buy
502,012
+286,840
+133% +$3.99M 3.3% 2
2025
Q4 		$1.91M Buy
+215,172
New +$1.85M 1.29% 12

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Seven Fleet Capital Management's TNGX Position: Q2 2026 in Review

Seven Fleet Capital Management increased its Tango Therapeutics (TNGX) stake by 543% in Q2 2026, buying an estimated $67.4M and bringing the position to 3,228,144 shares worth $95.7M. The position accounts for 15.79% of the portfolio, ranked #2.

Seven Fleet Capital Management first reported a position in TNGX in Q4 2025 and has held it in 3 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Seven Fleet Capital Management held 3,228,144 shares of Tango Therapeutics worth $95.7M as of Q2 2026.
  • Seven Fleet Capital Management bought 2,726,132 Tango Therapeutics shares in Q2 2026, an estimated $67.4M.
  • Tango Therapeutics made up 15.79% of Seven Fleet Capital Management's portfolio in Q2 2026, its #2 holding.
  • Seven Fleet Capital Management first reported a position in Tango Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Seven Fleet Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.